ARTICLE | Clinical News
Obecure reports obesity data
August 31, 2007 12:56 AM UTC
Obecure (Ramat Gan, Israel) said all three doses of Histalean (16, 32 and 48 mg/day) failed to show statistically significant differences in weight loss vs. placebo in a Phase II trial to treat obesit...